3-bromopyruvate induces morphological alteration and may initiate programmed cell death in Cryptococcus neoformans cells

Arch Microbiol. 2024 Mar 12;206(4):153. doi: 10.1007/s00203-024-03894-9.

Abstract

3-Bromopyruvate (3BP), known for its potent anticancer properties, also exhibits remarkable efficacy against the pathogenic fungus Cryptococcus neoformans. So far it has been proven that the main fungicidal activity of 3BP is based on ATP depletion and a reduction of intracellular level of glutathione. The presented study includes a broad range of methods to further investigate the mechanistic effects of 3BP on C. neoformans cells. The use of flow cytometry allowed a thorough examination of their survival during 3BP treatment, while observations using electron microscopy made it possible to note the changes in cellular morphology. Utilizing ruthenium red, the study suggests a mitochondrial pathway may initiate programmed cell death in response to 3BP. Analysis of free radical generation and gene expression changes supports this hypothesis. These findings enhance comprehension of 3BP's mechanisms in fungal cells, paving the way for its potential application as a therapeutic agent against cryptococcosis.

Keywords: Cryptococcus neoformans; 3-bromopyruvate; Free radicals; VDAC.

MeSH terms

  • Apoptosis
  • Cryptococcosis* / drug therapy
  • Cryptococcus neoformans* / metabolism
  • Pyruvates / metabolism
  • Pyruvates / pharmacology
  • Pyruvates / therapeutic use

Substances

  • bromopyruvate
  • Pyruvates